Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Notes Payables (2023 - 2025)

Zhengye Biotechnology Holding has reported Notes Payables over the past 3 years, most recently at $9.2 million for Q4 2025.

  • Quarterly Notes Payables fell 11.43% to $9.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.2 million through Dec 2025, down 11.43% year-over-year, with the annual reading at $9.3 million for FY2025, 8.73% down from the prior year.
  • Notes Payables was $9.2 million for Q4 2025 at Zhengye Biotechnology Holding, down from $11.3 million in the prior quarter.
  • Over five years, Notes Payables peaked at $11.3 million in Q2 2025 and troughed at $9.2 million in Q4 2025.
  • The 3-year median for Notes Payables is $10.7 million (2023), against an average of $10.5 million.
  • Year-over-year, Notes Payables decreased 6.56% in 2024 and then fell 11.43% in 2025.
  • A 3-year view of Notes Payables shows it stood at $11.1 million in 2023, then fell by 6.56% to $10.4 million in 2024, then decreased by 11.43% to $9.2 million in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Notes Payables are $9.2 million (Q4 2025), $11.3 million (Q2 2025), and $10.4 million (Q4 2024).